APIXABAN COMBIX 2.5 mg FILM-COATED TABLETS

2. What you need to know before you take Apixaban Combix

Do not takeApixaban Combix:

• to apixaban or any of the other ingredients of this medicine (listed in section 6)
• a disease in an organof the body that increases the risk of severe bleeding (such as an active or recent stomach or intestinal ulcer, or recent brain hemorrhage)
• a liver diseasethat increases the risk of bleeding (hepatic coagulopathy)
• medicines to prevent blood clotting(e.g., warfarin, rivaroxaban, dabigatran, or heparin), except when switching treatment, while having an arterial or venous line and being treated with heparin to keep the line open, or when having a tube inserted into a blood vessel (catheter ablation) to treat an irregular heartbeat (arrhythmia).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before taking this medicine if you have any of these conditions:

• an increased risk of bleeding, such as:
• • bleeding disorders, including situations that result in a decrease in platelet activity
  • very high blood pressure, not controlled by medical treatment
  • you are over 75 years old
  • you weigh 60 kg or less
• severe kidney disease or if you are on dialysis
• a liver problem or history of liver problems
• • This medicine will be used with caution in patients with signs of altered liver function
• you have had a catheter or injection in your spine(for anesthesia or pain relief), your doctor will tell you to wait at least 5 hours after removing the catheter before taking this medicine;
• you have a heart valve replacement;
• your doctor determines that your blood pressure is unstable or you are scheduled to receive another treatment or undergo surgery to remove the blood clot from your lungs.

Be careful with apixaban

• a disease called antiphospholipid syndrome (a disorder of the immune system that increases the risk of forming blood clots), inform your doctor to decide if it may be necessary to modify the treatment.

If you need to have surgery or a procedure that may cause bleeding, your doctor will tell you to temporarily stop taking this medicine for a while. If you are not sure if a procedure may cause bleeding, talk to your doctor.

Children and adolescents

This medicine is not recommended for use in children and adolescents under 18 years of age.

Other medicines and apixaban

Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use other medicines.

Some medicines may increase the effects of apixaban tablets and some medicines may decrease their effects. Your doctor will decide if you should be treated with apixaban tablets if you are taking these medicines and if you should be kept under closer observation.

The following medicines may increase the effects of apixaban tablets and increase the possibility of unwanted bleeding:

• some medicines for fungal infections(e.g., ketoconazole, etc.)
• some antiviral medicines for HIV/AIDS(e.g., ritonavir)
• other medicines to reduce blood clotting(e.g., enoxaparin, etc.)
• anti-inflammatory or pain-relieving medicines(e.g., acetylsalicylic acid or naproxen). In particular, if you are over 75 years old and taking acetylsalicylic acid, there is a higher likelihood of bleeding.
• medicines for high blood pressure or heart problems(e.g., diltiazem)
• antidepressants called selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors.

The following medicines may reduce the ability of apixaban tablets to prevent blood clot formation:

• medicines for the treatment of epilepsy or seizures(e.g., phenytoin, etc.)
• St. John's Wort(a plant-based supplement for the treatment of depression)
• medicines for the treatment of tuberculosis or other infections(e.g., rifampicin)

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before taking this medicine.

The effects of apixaban tablets on pregnancy and the fetus are not known. You should not take this medicine if you are pregnant contact your doctor immediatelyif you become pregnant while taking this medicine.

It is not known if apixaban tablets are excreted in human milk. Ask your doctor, pharmacist, or nurse for advice before taking this medicine during breastfeeding. They will tell you whether to stop breastfeeding or whether to stop or not start taking this medicine.

Driving and using machines

Apixaban tablets have not been shown to decrease the ability to drive or use machines.

Apixaban Combix contains lactose (a type of sugar) and sodium

This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, talk to your doctor before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially “sodium-free”.

3. How to take Apixaban Combix

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor, pharmacist, or nurse again.

Dosage

Take the tablet with water. Apixaban tablets can be taken with or without food.

Try to take the tablets at the same time each day to achieve a better effect of the treatment.

If you have difficulty swallowing the whole tablet, talk to your doctor about other possible ways to take the apixaban tablets. The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking it.

Instructions for crushing:

• Crush the tablets with a mortar.
• Transfer all the powder carefully into a suitable container, mixing the powder with a small amount, e.g., 30 ml (2 tablespoons), of water or any of the other liquids mentioned to make the mixture.
• Take the mixture.
• Rinse the mortar and pestle used to crush the tablet and the container with a small amount of water or one of the other liquids (e.g., 30 ml), and take that liquid.

If necessary, your doctor may also administer the crushed apixaban tablet mixed in 60 ml of water or 5% glucose in water through a nasogastric tube.

Take apixaban tablets according to the following recommendations:

To prevent the formation of blood clots in hip or knee replacement surgery.

The recommended dose is one apixaban 2.5 mg tablet twice a day. For example, take one tablet in the morning and one in the evening.

You should take the first tablet between 12 and 24 hours after surgery.

If you have had hipsurgery, you will usually take the tablets for a period of 32 to 38 days.

If you have had kneesurgery, you will usually take the tablets for a period of 10 to 14 days.

To prevent the formation of a blood clot in the heart in patients with an irregular heartbeat and at least one additional risk factor.

The recommended dose is one apixaban 5 mgtablet twice a day.

The recommended dose is one apixaban 2.5 mgtablet twice a day if:

• you have severely reduced kidney function
• you have two or more of the following factors:
• • your blood test results suggest poor kidney function (the serum creatinine value is 1.5 mg/dL (133 micromoles/L) or higher)
  • you are 80 years old or older
  • your weight is 60 kg or less.

The recommended dose is one tablet twice a day, for example, take one tablet in the morning and one in the evening. Your doctor will tell you how long you should continue the treatment.

To treat blood clots in the veins of the legs and in the blood vessels of the lungs.

The recommended dose is twoapixaban 5 mgtablets twice a day for the first 7 days, for example, two tablets in the morning and two tablets in the evening.

After 7 days, the recommended dose is oneapixaban 5 mgtablet twice a day, for example, one tablet in the morning and one in the evening.

To prevent blood clots from recurring after 6 months of treatment.

The recommended dose is one apixaban 2.5 mgtablet twice a day, for example, one tablet in the morning and one in the evening.

Your doctor will tell you how long you should continue the treatment.

Your doctor may change your anticoagulant treatment as follows:

• Switching from apixaban tablets to other anticoagulant medicines

Stop taking apixaban tablets. Start treatment with other anticoagulant medicines (e.g., heparin) at the time you would take the next apixaban tablet.

• Switching from other anticoagulant medicines to apixaban tablets

Stop taking other anticoagulant medicines. Start treatment with apixaban tablets at the time you would take the next dose of the other anticoagulant medicine, and then continue as usual.

• Switching from treatment with anticoagulants that contain vitamin K antagonists (e.g., warfarin) to apixaban tablets

Stop taking the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to start taking apixaban tablets.

• Switching from treatment with apixaban tablets to treatment with anticoagulants that contain vitamin K antagonists (e.g., warfarin)

If your doctor tells you to start taking a medicine that contains a vitamin K antagonist, continue taking apixaban tablets for at least 2 days after your first dose of the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to stop taking apixaban tablets.

Patients undergoing cardioversion

If your heartbeat needs to be restored through a process called cardioversion, take this medicine at the times your doctor tells you to prevent blood clots in the blood vessels of the brain and other blood vessels in the body.

If you take more Apixaban Combix than you should

Tell your doctor immediatelyif you have taken a dose higher than the prescribed dose of this medicine. Take the package of the medicine to your doctor, even if there are no tablets left.

If you take more apixaban tablets than the recommended dose, you may increase the risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that can reverse the anti-factor Xa activity may be necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91562 04 20, indicating the medicine and the amount taken.

If you forget to take Apixaban Combix

• Take the dose as soon as you remember and:

• take the next apixaban dose at the usual time
• then continue taking the medicine as usual.

If you are in doubt about what to do or if you forget to take more than one dose, ask your doctor, pharmacist, or nurse.

If you stop taking Apixaban Combix

Do not stop taking this medicine without talking to your doctor first, because the risk of developing a blood clot may be higher if you stop the treatment too soon.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Apixaban tablets can be administered in three different diseases. The known adverse effects and the frequency at which they occur may be different and are therefore indicated separately below. For these conditions, the most frequent adverse effect of this medicine is bleeding, which can endanger the patient's life and requires immediate medical attention.

The following adverse effects have been reported when taking apixaban tablets to prevent the formation of blood clots in hip or knee replacement operations.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Anemia, which can cause fatigue or paleness.
• Bleeding, including:

• hematoma and swelling.

• Nausea (general discomfort).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Decreased platelet count in blood (which can affect coagulation).
• Bleeding:

• after surgery, including hematoma and swelling, bleeding or fluid discharge from the wound/surgical incision (suppuration), or at the injection site.
• from the stomach, intestine, or bright red blood in the stool.
• blood in the urine.
• from the nose.
• vaginal.

• Low blood pressure, which can cause fainting or a faster heart rate.
• Blood tests may show:

• abnormal liver function.
• increased liver enzymes.
• increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes.

• Itching.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.
• Bleeding.

• in a muscle.
• in the eyes.
• from the gums and coughing up blood.
• from the rectum.

• Hair loss.

Unknown Frequency (cannot be estimated from available data)

• Bleeding:

• in the brain or spinal cord.
• in the lungs or throat.
• in the mouth.
• in the abdomen or the space behind the abdominal cavity.
• hemorrhoidal.
• tests showing blood in the stool or urine.

• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).
• Inflammation of blood vessels (vasculitis) that can cause skin rash, appearance of round, smooth red spots under the skin surface, or hematomas.
• Bleeding in the kidney, sometimes with blood in the urine, which can cause the kidneys to fail to function properly (anticoagulant-related nephropathy).

The following adverse effects have been reported when taking apixaban tablets to prevent the formation of blood clots in the heart in patients with irregular heartbeats and at least one additional risk factor.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Bleeding, including:

• in the eyes.
• in the stomach or intestine.
• from the rectum.
• blood in the urine.
• from the nose.
• from the gums.
• hematoma and swelling.

• Anemia, which can cause fatigue or paleness.
• Low blood pressure, which can cause fainting or a faster heart rate.
• Nausea (general discomfort).
• Blood tests may show:

• an increase in gamma glutamyl transferase (GGT).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Bleeding:

• in the brain or spinal cord.
• in the mouth or coughing up blood.
• in the abdomen or vagina.
• bright red blood in the stool.
• bleeding after surgery, including hematoma and swelling, bleeding or fluid discharge from the wound/surgical incision (suppuration), or at the injection site.
• hemorrhoidal.
• tests showing blood in the stool or urine.

• Decreased platelet count in blood (which can affect coagulation).
• Blood tests may show:

• abnormal liver function.
• increased liver enzymes.
• increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes.

• Skin rash.
• Itching.
• Hair loss.
• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Bleeding:

• in the lungs or throat.
• within the space behind the abdominal cavity.
• in a muscle.

Very Rare Adverse Effects (may affect up to 1 in 10,000 people)

Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).

Unknown Frequency (cannot be estimated from available data)

• Inflammation of blood vessels (vasculitis) that can cause skin rash, appearance of round, smooth red spots under the skin surface, or hematomas.
• Bleeding in the kidney, sometimes with blood in the urine, which can cause the kidneys to fail to function properly (anticoagulant-related nephropathy).

The following adverse effects have been reported when taking apixaban tablets to treat or prevent blood clots from recurring in the veins of the legs and in the blood vessels of the lungs.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Bleeding, including:

• from the nose.
• from the gums.
• blood in the urine.
• hematoma and swelling.
• from the stomach, intestine, or rectum.
• in the mouth.
• vaginal.

• Anemia, which can cause fatigue or paleness.
• Decreased platelet count in blood (which can affect coagulation).
• Nausea (general discomfort).
• Skin rash.
• Blood tests may show:

• an increase in gamma glutamyl transferase (GGT) or alanine aminotransferase (GPT).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Low blood pressure, which can cause fainting or a faster heart rate.
• Bleeding:

• in the eyes.
• in the mouth or coughing up blood.
• bright red blood in the stool.
• tests showing blood in the stool or urine.
• bleeding after surgery, including hematoma and swelling, bleeding or fluid discharge from the wound/surgical incision (suppuration), or at the injection site.
• hemorrhoidal.
• in a muscle.

• Itching.
• Hair loss.
• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Contact your doctor immediately if you experience any of these symptoms.
• Blood tests may show:

• abnormal liver function.
• increased liver enzymes.
• increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Bleeding:

• in the brain or spinal cord.
• in the lungs.

Unknown Frequency (cannot be estimated from available data)

• Bleeding:

• in the abdomen or the space behind the abdominal cavity.

• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).
• Inflammation of blood vessels (vasculitis) that can cause skin rash, appearance of round, smooth red spots under the skin surface, or hematomas.
• Bleeding in the kidney, sometimes with blood in the urine, which can cause the kidneys to fail to function properly (anticoagulant-related nephropathy).

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Apixaban Combix

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date shown on the packaging and blister, after CAD. The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions.

Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Apixaban Combix 2.5 mg film-coated tablets

• The active ingredient is apixaban. Each tablet contains 2.5 mg of apixaban.
• The other ingredients are:
• Core of the tablet: hypromellose, stearic acid, anhydrous lactose, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.
• Coating: lactose monohydrate, hypromellose, titanium dioxide (E171), and triacetin. See section 2 "apixaban tablets contain lactose (a type of sugar) and sodium".

Appearance of the Product and Package Contents

Apixaban Combix 2.5 mg are white to off-white, round, film-coated tablets, engraved with "1181" on one side and flat on the other.

• The tablets are presented in blisters in packages of 10, 20, 60, 168, and 200 film-coated tablets.
• Unit dose blisters are also available, presented in clinical packages containing 60x1 and 100x1 film-coated tablets.

Not all package sizes may be marketed.

Patient Information Card: Information Management

Inside the Apixaban Combix package, along with the prospectus, you will find a Patient Information Card or your doctor may give you a similar card.

This Patient Information Card includes useful information for you and will alert other doctors that you are being treated with apixaban. You should keep this card with you at all times.

1. Take the card.
2. Separate the language you need (this is facilitated through the perforated ends).
3. Complete the following sections or ask your doctor to complete them:
   • Name:
   • Date of birth:
   • Indication:
   • Dose: ........mg twice a day.
   • Doctor's name:
   • Doctor's phone number:
4. Fold the card and carry it with you at all times.

Marketing Authorization Holder

Laboratorios Combix, S.L.U.

C/ Badajoz 2, Edificio 2.

28223 Pozuelo de Alarcón (Madrid).

Spain.

Manufacturer

Zydus France.

ZAC Les Hautes Patures.

Parc d'activités des Peupliers.

25 Rue des Peupliers.

92000 Nanterre.

France.

Or.

Pharmex Advanced Laboratories S.L.

Ctra. A-431 Km. 19.

14720 Almodóvar del Río (Córdoba).

Spain.

Or.

Centre Spécialités Pharmaceutiques.

ZAC des Suzots.

35 rue de la Chapelle.

63450 Saint Amant Tallende.

France.

Or.

Netpharmalab Consulting Services S.L.

Carretera de Fuencarral 22.

Alcobendas.

28108 Madrid.

Spain.

Date of the Last Revision of this Prospectus:May 2025.

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.